Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Reuteri DSM 17938 for Infant Colic
NCT02574065Unknown
- Sponsor
- Shanghai Children's Hospital
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing L. reuteri DSM 17938 group with Placebo group (2 arms). Primary endpoints: Daily crying time measured at Day 7, Daily crying time measured at Day 14 and 1 more. Status: unknown.
02
Drugs
Lactobacillus reuteri DSM 17938
Beyond the preview
Go deeper on NCT02574065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574065.